-
Exvastat is an innovative, clinical-stage pharmaceutical company founded in 2016, led by a small experienced management team with nearly 50 years combined pharmaceutical experience.
The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications.
